ArticleOncoimmunology2023

23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function.

Jill Fenaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.